Literature DB >> 10660520

Specific requirement for the p85-p110alpha phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells.

K Hill1, S Welti, J Yu, J T Murray, S C Yip, J S Condeelis, J E Segall, J M Backer.   

Abstract

We have studied the role of phosphatidylinositol 3-kinases (PI 3-kinases) in the regulation of the actin cytoskeleton in MTLn3 rat adenocarcinoma cells. Stimulation of MTLn3 cells with epidermal growth factor (EGF) induced a rapid increase in actin polymerization, with production of lamellipodia within 3 min. EGF-stimulated lamellipodia were blocked by 100 nM wortmannin, suggesting the involvement of a class Ia PI 3-kinase. MTLn3 cells contain equal amounts of p110alpha and p110beta, and do not contain p110delta. Injection of specific inhibitory antibodies to p110alpha induced cell rounding and blocked EGF-stimulated lamellipod extension, whereas control or anti-p110beta antibodies had no effect. In contrast, both antibodies inhibited EGF-stimulated DNA synthesis. An in situ assay for actin nucleation showed that EGF-stimulated formation of new barbed ends was blocked by injection of anti-p110alpha antibodies. In summary, the p110alpha isoform of PI 3-kinase is specifically required for EGF-stimulated actin nucleation during lamellipod extension in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660520     DOI: 10.1074/jbc.275.6.3741

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase.

Authors:  Lei Bi; Ichiro Okabe; David J Bernard; Robert L Nussbaum
Journal:  Mamm Genome       Date:  2002-03       Impact factor: 2.957

2.  The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via phosphatidylinositol 3-kinase.

Authors:  V J Fincham; V G Brunton; M C Frame
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  PLA2 and PI3K/PTEN pathways act in parallel to mediate chemotaxis.

Authors:  Lingfeng Chen; Miho Iijima; Ming Tang; Mark A Landree; Yi Elaine Huang; Yuan Xiong; Pablo A Iglesias; Peter N Devreotes
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

4.  Quantification of PtdIns(3,4,5)P(3) dynamics in EGF-stimulated carcinoma cells: a comparison of PH-domain-mediated methods with immunological methods.

Authors:  Shu-Chin Yip; Robert J Eddy; Angie M Branch; Huan Pang; Haiyan Wu; Ying Yan; Beth E Drees; Paul O Neilsen; John Condeelis; Jonathan M Backer
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

5.  Role of phosphoinositide 3-OH kinase p110β in skeletal myogenesis.

Authors:  Ronald W Matheny; Melissa A Riddle-Kottke; Luis A Leandry; Christine M Lynch; Mary N Abdalla; Alyssa V Geddis; David R Piper; Jean J Zhao
Journal:  Mol Cell Biol       Date:  2015-01-20       Impact factor: 4.272

Review 6.  PI3K: from the bench to the clinic and back.

Authors:  Bart Vanhaesebroeck; Peter K Vogt; Christian Rommel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase.

Authors:  Huan Pang; Rory Flinn; Antonia Patsialou; Jeffrey Wyckoff; Evanthia T Roussos; Haiyan Wu; Maria Pozzuto; Sumanta Goswami; John S Condeelis; Anne R Bresnick; Jeffrey E Segall; Jonathan M Backer
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

Review 8.  The regulation of cell motility and chemotaxis by phospholipid signaling.

Authors:  Verena Kölsch; Pascale G Charest; Richard A Firtel
Journal:  J Cell Sci       Date:  2008-03-01       Impact factor: 5.285

9.  Chronophin coordinates cell leading edge dynamics by controlling active cofilin levels.

Authors:  Violaine Delorme-Walker; Ji-Yeon Seo; Antje Gohla; Bruce Fowler; Ben Bohl; Céline DerMardirossian
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

10.  Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion.

Authors:  Marc A Antonyak; Bo Li; Andrew D Regan; Qiyu Feng; Stephanie S Dusaban; Richard A Cerione
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.